About Sight Science
Sight Science is a company based in Shoreview (United States) founded in 2006 by Paul Badawi was acquired by NovaVision in January 2012. Sight Science has raised $7.52 million across 2 funding rounds from investors including NovaVision, SHD Partners and Allegro Investment Fund. The company has 204 employees as of December 31, 2021. Sight Science operates in a competitive market with competitors including NovaVision, Bionic Vision Technologies, Amblyotech, Ooyby and Envision Solutions, among others.
- Headquarter Shoreview, United States
- Employees 204 as on 31 Dec, 2021
- Founders Paul Badawi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.52 M (USD)
in 2 rounds
-
Latest Funding Round
$7 M (USD), Series B
Mar 15, 2016
-
Investors
NovaVision
& 2 more
-
Employee Count
204
as on Dec 31, 2021
-
Acquired by
NovaVision
(Jan 10, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sight Science
Sight Science has successfully raised a total of $7.52M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sight Science
Sight Science has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include NovaVision, SHD Partners and Allegro Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on early-stage MedTech investments.
|
Locked | Locked | Locked | |
|
A private investment fund supporting entrepreneurial businesses with strategic resources.
|
Locked | Locked | Locked | |
|
Non-invasive devices are developed for vision restoration in stroke survivors.
|
Locked | Locked | Locked |
Investor details for Sight Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sight Science
Investment portfolio details for Sight Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sight Science
Detailed financials for Sight Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sight Science Comparisons
Peer comparison for Sight Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sight Science
Sight Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NovaVision, Bionic Vision Technologies, Amblyotech, Ooyby and Envision Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| Locked | Locked | Locked |
Visual prostheses are developed to restore sight for the blind.
|
|
| Locked | Locked | Locked |
An app-based treatment for Amblyopia is provided through visual games.
|
|
| Locked | Locked | Locked |
Smart devices are provided for vision rehabilitation and training.
|
|
| Locked | Locked | Locked |
Delivers comprehensive computer-based therapies for vision restoration.
|
Detailed competitors of Sight Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sight Science
Complete news archive for Sight Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sight Science
Sight Science was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Sight Science is headquartered in Shoreview, United States. It is registered at Shoreview, Minnesota, United States.
Paul Badawi is the current CEO of Sight Science. They have also founded this company.
Sight Science is a funded company, having raised a total of $7.52M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Sight Science is 204.
Sight Science was established in 2006 in Shoreview, United States, within the healthcare sector. Focus is placed on visual rehabilitation services for individuals affected by visual field loss from brain injuries. The Neuro-Eye Therapy program is utilized, employing a computer-based device for treatment. Initial joint ownership was shared between Dr. Sahraie and the University of Aberdeen, Scotland. Operations center on therapeutic interventions for neurological visual impairments.
Sight Science's top competitors include NovaVision, Bionic Vision Technologies and Ooyby.
Sight Science has 3 investors. Key investors include NovaVision, SHD Partners, and Allegro Investment Fund.